Patrick Tobbia1, MD; Bruce R. Brodie1*, MD; Bernhard Witzenbichler2, MD; Chris Metzger3, MD; Giulio Guagliumi4, MD; Jennifer Yu5, MD; Mirle A. Kellett6, MD; Thomas Stuckey1, MD; Martin Fahy7, MSc; Roxana Mehran5,7, MD; Gregg W. Stone7,8, MD
1. LeBauer Cardiovascular Research Foundation and Moses Cone Hospital, Greensboro, NC, USA; 2. Charité Campus Benjamin Franklin, Berlin, Germany; 3. Wellmont CVA Heart Institute, Kingsport, TN, USA; 4. Ospedali Riuniti di Bergamo, Berga
Aims: To examine outcomes in patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary interve